Chilean government adopts national plan on dementia

8 November 2017 – The government of Chile has adopted a national plan on dementia. The plan is the 30th to be adopted worldwide and outlines increased support for 180,000 people living with dementia. [read more]

Souvenaid results lead way for more research on nutrition

31 October 2017 – The Lancet Neurology has published results on the effects of health supplement Souvenaid™. The results do not show a significant improvement in cognition but do show some promising findings for continuing research. [read more]

Alzheimer Bolivia lead international training on development of dementia plans

22 October 2017 - A workshop was organised in Dominican Republic, training participants from across the Ibero-America region in strategies for working with government agencies in the development of national dementia plans. [read more]

Elevator pitch: A short story about the needs and hopes of Africa

17 October 2017 – Paola Barbarino, CEO, explains why stigma presents a major challenge for addressing dementia in sub-Saharan Africa – and how taking an elevator can lead to greater support. [read the full blog]

President of Costa Rica becomes ADI Ambassador

13 October 2017 – The President of Costa Rica has become an Honorary Ambassador of Alzheimer’s Disease International (ADI) after affirming the commitment of the country to global action on dementia. [read more]

ADI appoints Regional Director for the Americas

9 October 2017 – Joost Martens has been appointed as ADI's Regional Director for the Americas. The role will actively support and strengthen the role of Alzheimer associations and response to dementia in the region. [read more]

ADI welcomes new Director of Policy, Communication and Publications

2 October 2017 – Chris Lynch has been appointed as ADI's Director of Policy, Communication and Publications and Deputy CEO. Chris has joined the team in London after almost 5 years as Deputy Director for Communications, Marketing and Events for Alzheimer Scotland. [read more]

Dementia in sub-Saharan Africa: Challenges and opportunities

28 September 2017 – ADI has published its first report on the impact of dementia in sub-Saharan Africa. The report presents new research and calls for urgent action to improve awareness, access to health services and social protection in the region. [read the report]

£7.7 million study to strengthen responses to dementia in developing countries

27 September 2017 – The London School of Economics and Political Science (LSE), Alzheimer’s Disease International (ADI) and Dementia Alliance International (DAI) will lead a £7.7 million project to build research capacity and provide much-needed evidence on dementia care in seven low and middle-income countries. [read more]

Dementia drug trial fails during World Alzheimer's Month

26 September 2017 – End stage trials for potential new Alzheimer’s Disease drug Intepirdine have failed to show positive results. Alzheimer’s Disease International (ADI) welcomes more research into new treatments, urging that global investment must continue to enhance prevention, earlier diagnosis and care. [read more]